GLP-1 receptor agonist use may lower vertebral fracture risk with type 2 diabetes
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) may protect against vertebral fractures in people with diabetes, according to a research letter published online Dec. 10 in JAMA Surgery.This article was originally published on MedicalXpress.com
